Tempest Therapeutics
TPST
#10299
Rank
A$2.73 M
Marketcap
$0.78
Share price
-1.03%
Change (1 day)
-85.16%
Change (1 year)

EPS for Tempest Therapeutics (TPST)

EPS in 2023 (TTM): -$3.57

According to Tempest Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.71. In 2022 the company made an earnings per share (EPS) of -$5.08 an increase over its 2021 EPS that were of -$16.80.

EPS history for Tempest Therapeutics from 2021 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.57-29.7%
2022-$5.08-69.74%
2021-$16.80